Giallongo Cesarina, Tibullo Daniele, Parrinello Nunziatina L, La Cava Piera, Di Rosa Michelino, Bramanti Vincenzo, Di Raimondo Cosimo, Conticello Concetta, Chiarenza Annalisa, Palumbo Giuseppe A, Avola Roberto, Romano Alessandra, Di Raimondo Francesco
Division of Hematology, A.O.U. Policlinico-OVE, Catania, University of Catania, Italy.
Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
Oncotarget. 2016 Dec 27;7(52):85764-85775. doi: 10.18632/oncotarget.7969.
Granulocytic-Myeloid-derived suppressor cells (G-MDSC) are increased in Multiple Myeloma (MM) patients but the mechanisms of G-MDSC generation are still unknown. There are many evidences of the role of mesenchymal stem cells (MSC) in promoting MM cell growth, survival and drug-resistance. We here used a specific experimental model in vitro to evaluate the ability of MSC to induce G-MDSC. We found that although MSC derived from healthy donors (HD), MGUS and MM were able to generate the same amount of MDSC, only MM-MSC-educated G-MDSC exhibited suppressive ability. In addition, in comparison with MSC derived from HD, MM-MSC produce higher amount of immune-modulatory factors that could be involved in MDSC induction. Compared to G-MDSC obtained from co-culture models with MSC from healthy subjects, both MGUS and MM-MSC-educated G-MDSC showed increase of immune-modulatory factors. However, only MM-MSC educated G-MDSC 1) up-regulated immune-suppressive factors as ARG1 and TNFα, 2) expressed higher levels of PROK2, important in angiogenesis and inflammatory process, and 3) showed ability to digest bone matrix.Our data demonstrate that MM-MSC are functionally different from healthy subjects and MGUS-MSC, supporting an evolving concept regarding the contribution of MM-MSC to tumor development and progression.
粒细胞-髓系来源的抑制性细胞(G-MDSC)在多发性骨髓瘤(MM)患者中数量增加,但G-MDSC产生的机制仍不清楚。有许多证据表明间充质干细胞(MSC)在促进MM细胞生长、存活和耐药方面发挥作用。我们在此使用体外特定实验模型来评估MSC诱导G-MDSC的能力。我们发现,尽管来自健康供体(HD)、意义未明的单克隆丙种球蛋白病(MGUS)和MM的MSC能够产生相同数量的MDSC,但只有经MM-MSC诱导的G-MDSC具有抑制能力。此外,与来自HD的MSC相比,MM-MSC产生更高水平的免疫调节因子,这些因子可能参与MDSC的诱导。与从与健康受试者的MSC共培养模型中获得的G-MDSC相比,MGUS和经MM-MSC诱导的G-MDSC均显示免疫调节因子增加。然而,只有经MM-MSC诱导的G-MDSC:1)上调免疫抑制因子如精氨酸酶1(ARG1)和肿瘤坏死因子α(TNFα);2)表达更高水平的PROK2,其在血管生成和炎症过程中起重要作用;3)显示出消化骨基质的能力。我们的数据表明,MM-MSC在功能上不同于健康受试者和MGUS-MSC,这支持了关于MM-MSC在肿瘤发生和进展中作用的一个不断发展的概念。